The United States: GRAS Status and a First-of-Its-Kind Label Rule
Allulose entered the US food supply through the FDA's GRAS pathway in 2014, on the strength of toxicology and clinical data — including long-term animal work by Iida and colleagues showing no adverse effects from chronic intake (Journal of Clinical Biochemistry and Nutrition, 2010, doi.org/10.3164/jcbn.09-93).
The bigger regulatory moment came in 2019: FDA guidance (Docket FDA-2019-D-0725) allowed allulose to be excluded from "Total Sugars" and "Added Sugars" on the Nutrition Facts label — recognition that it is not metabolized like ordinary sugar. That decision unlocked rapid adoption: as of 2026, allulose appears in American ice cream, candy, beverages, and baked goods. The safety file behind these decisions is unpacked in our clinical trials summary.
Japan: Where Rare-Sugar Science Started
Japan treats allulose as an ordinary food — not a food additive — with no special use restrictions. That quiet status hides an outsized scientific role: researchers at Kagawa University, led by Ken Izumori, spent the 1990s building the systematic study of rare sugars and published the "Izumoring" framework — a complete map for converting one rare sugar into another (Journal of Biotechnology, 2006, doi.org/10.1016/j.jbiotec.2006.01.010).
Japanese products can now carry approved function claims about allulose moderating post-meal blood glucose under the country's functional-food labeling system — the mechanism is explained in our blood sugar guide.
South Korea: The Production Powerhouse
Korea's Ministry of Food and Drug Safety (MFDS) approved allulose as a food ingredient in 2016, and Korean manufacturers — with deep patent portfolios in enzymatic conversion — became some of the world's largest producers. Reviews of production technology, including the Korean contribution, are covered in Hossain and colleagues' overview of D-allulose applications (Applied Microbiology and Biotechnology, 2015, doi.org/10.1007/s00253-015-6757-6).
On the ground, Korea is arguably the world's most visible allulose market: convenience stores routinely stock zero-sugar chocolates, ice creams, and drinks sweetened with it, and low-sugar allulose beverages have appeared in school-adjacent settings.
The EU: Not a Safety Problem — a Process
In the EU, allulose is classified as a Novel Food under Regulation 2015/2283: any food without significant EU consumption history before 1997 requires a full safety evaluation by EFSA and authorization by the European Commission before sale. The process is rigorous by design and typically takes years.
The key point for parents: "not yet approved in the EU" reflects the queue, not the data. Published safety reviews consistently support allulose at realistic intakes (see the comprehensive review in Nutrients, 2019, doi.org/10.3390/nu11092340), and multiple applications are moving through the EFSA pipeline. An EU authorization, when it comes, would likely accelerate approvals in other markets that watch European decisions.
The Rest of the Map
| Country / region | Status | Notes |
|---|---|---|
| United States | GRAS (2014) + label exclusion (2019) | Broad commercial use across food categories |
| Japan | Sold as ordinary food | Birthplace of rare-sugar research; functional-label products on market |
| South Korea | Approved (2016) | Major producer; mainstream zero-sugar product category |
| Singapore | Approved (2019) | SFA approval; Nutri-Grade drink rating boosts demand for low-sugar options |
| Taiwan | Approved (2020) | Permitted in foods; use expanding |
| EU | Novel Food review underway | EFSA evaluation in progress; process, not safety, is the holdup |
| China | Under evaluation | National standard development in progress |
| India | Early evaluation | FSSAI assessment at an early stage |
| Australia / NZ | Under consideration | FSANZ in information-gathering phase |
The pattern is easy to read: every regulator that has completed a review has approved allulose, and the markets still pending are pending on process. WHO guidance urging lower free-sugar intake keeps the demand side pushing in the same direction.
What Approval Means for Your Family — and What It Doesn't
Regulatory approval answers "is this safe for general use?" — it doesn't set your child's portions. The shared evidence base regulators reviewed includes 90-day repeated-dose toxicology with no adverse findings, negative genotoxicity screening (Ames, chromosome aberration, micronucleus), reproductive toxicity studies showing no next-generation effects, and human tolerance data at meaningful daily intakes.
Dedicated pediatric trials remain limited, so the household rule stays the same everywhere on the map: weight-based servings, started small. Practical amounts by age — roughly 1-2 g for toddlers, 3-5 g for preschoolers, 5-10 g for school-age kids per day — are laid out in our allulose safety guide for kids, and the extended-use evidence lives in the long-term studies review. New to allulose entirely? Start with the complete guide.
One bonus for curious school-age kids: "why do countries approve foods differently?" is a genuinely great dinner-table question — food-safety literacy in one conversation.
Frequently Asked Questions
Is allulose legal in the US?
Yes — GRAS since 2014, with the 2019 label rule excluding it from total and added sugars. It's now common across US food categories.
Does the EU delay mean it's unsafe?
No. The EU's Novel Food process requires a full EFSA evaluation regardless of other countries' decisions, and it simply takes years. Published reviews consistently support allulose safety.
Which Asian markets allow it?
Korea (2016), Singapore (2019), and Taiwan (2020) have approved it; Japan treats it as an ordinary food. China and India are evaluating.
Can I buy allulose products abroad and bring them home?
Products from approved markets meet local safety standards, and personal-use quantities are generally fine to carry home. Read ingredient lists carefully — allergen labeling rules differ by country.
Are child-specific limits set anywhere?
No regulator has set child-specific allulose restrictions. Weight-based household portions — the same ones covered in our kids' safety guide — remain the sensible standard.
References and Further Reading
- Izumori K. "Izumoring: a strategy for bioproduction of all hexoses." Journal of Biotechnology, 2006. doi.org/10.1016/j.jbiotec.2006.01.010
- Iida T, et al. "Chronic effects of D-psicose on blood glucose and body fat in rats." Journal of Clinical Biochemistry and Nutrition, 2010. doi.org/10.3164/jcbn.09-93
- Hossain A, et al. "Rare sugar D-allulose: potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus." Applied Microbiology and Biotechnology, 2015. doi.org/10.1007/s00253-015-6757-6
- Hossain A, et al. Comprehensive review of D-allulose safety and metabolism. Nutrients, 2019. doi.org/10.3390/nu11092340
- US FDA. "The Declaration of Allulose and Calories from Allulose on Nutrition and Supplement Facts Labels: Guidance for Industry." Docket FDA-2019-D-0725, 2019.
- EU Regulation 2015/2283 on Novel Foods; WHO. "Guideline: Sugars intake for adults and children."
AI Privacy and Accuracy Note
This article was produced with AI writing assistance and reviewed against the regulatory documents and published research cited above. Regulatory statuses reflect publicly available information as of the last-updated date and can change as agencies complete reviews. This is educational information — not medical or legal advice. Portion decisions for children belong with parents, ideally in conversation with a pediatrician or registered dietitian; AI-organized information is a starting point, not a final answer.